ZAP Surgical Systems, Inc., a global leader in non-invasive robotic brain surgery, today announced a landmark clinical ...
This approval represents a significant regulatory milestone, making Proliv™Rx the first and only at-home neuromodulation ...
Neurolief Inc., a medical device company focused on neuromodulation therapies for neuropsychiatric conditions, today ...
The wearable device delivers electrical impulses through a headset that can be administered by the patient at home under physician oversight.
For individuals with major depressive disorder (MDD) that does not respond to pharmacotherapy, recent decisions by the U.S.
Neurolief announced today that the FDA granted approval for its Proliv Rx at-home neuromodulation therapy for treating ...
The clinical trial is expected to enroll up to 40 patients in two stages: an initial open-label pilot (10 patients) followed by a randomized, double-blinded, sham-controlled trial (30 patients).
Swedish neurotech startup Flow Neuroscience has secured FDA approval for the first brain stimulation device for home use in ...
TIESA will use Open-LIFU in AI-guided, noninvasive research on neuromodulation for mental health conditions. SAN ...
Neuromodulation is the process by which nervous activity is regulated by way of controlling the physiological levels of several classes of neurotransmitters. Image Credit: KateStudio/Shutterstock.com ...
As we enter 2026, there are two distinct technologies used by clinicians to interact with the brain: Brain-Computer ...
Overactive bladder (OAB) affects millions of people worldwide yet first-line treatments are often poorly tolerated and compliance rates are low. Neuromodulation works via afferent nerve modulation and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback